Copyright Reports & Markets. All rights reserved.

Global Sophocarpidine (CAS：519-02-8) Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Sophocarpidine (CAS：519-02-8)

      • 1.1 Definition of Sophocarpidine (CAS：519-02-8)
      • 1.2 Sophocarpidine (CAS：519-02-8) Segment by Type
        • 1.2.1 Global Sophocarpidine (CAS：519-02-8) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 High Purity
        • 1.2.3 Low Purity
      • 1.3 Sophocarpidine (CAS：519-02-8) Segment by Applications
        • 1.3.1 Global Sophocarpidine (CAS：519-02-8) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Pharmaceuticals
        • 1.3.3 Pesticides
        • 1.3.4 Others
      • 1.4 Global Sophocarpidine (CAS：519-02-8) Overall Market
        • 1.4.1 Global Sophocarpidine (CAS：519-02-8) Revenue (2014-2025)
        • 1.4.2 Global Sophocarpidine (CAS：519-02-8) Production (2014-2025)
        • 1.4.3 North America Sophocarpidine (CAS：519-02-8) Status and Prospect (2014-2025)
        • 1.4.4 Europe Sophocarpidine (CAS：519-02-8) Status and Prospect (2014-2025)
        • 1.4.5 China Sophocarpidine (CAS：519-02-8) Status and Prospect (2014-2025)
        • 1.4.6 Japan Sophocarpidine (CAS：519-02-8) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Sophocarpidine (CAS：519-02-8) Status and Prospect (2014-2025)
        • 1.4.8 India Sophocarpidine (CAS：519-02-8) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Sophocarpidine (CAS：519-02-8)
      • 2.3 Manufacturing Process Analysis of Sophocarpidine (CAS：519-02-8)
      • 2.4 Industry Chain Structure of Sophocarpidine (CAS：519-02-8)

      3 Development and Manufacturing Plants Analysis of Sophocarpidine (CAS：519-02-8)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Sophocarpidine (CAS：519-02-8) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Sophocarpidine (CAS：519-02-8)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Sophocarpidine (CAS：519-02-8) Production and Capacity Analysis
      • 4.2 Sophocarpidine (CAS：519-02-8) Revenue Analysis
      • 4.3 Sophocarpidine (CAS：519-02-8) Price Analysis
      • 4.4 Market Concentration Degree

      5 Sophocarpidine (CAS：519-02-8) Regional Market Analysis

      • 5.1 Sophocarpidine (CAS：519-02-8) Production by Regions
        • 5.1.1 Global Sophocarpidine (CAS：519-02-8) Production by Regions
        • 5.1.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Regions
      • 5.2 Sophocarpidine (CAS：519-02-8) Consumption by Regions
      • 5.3 North America Sophocarpidine (CAS：519-02-8) Market Analysis
        • 5.3.1 North America Sophocarpidine (CAS：519-02-8) Production
        • 5.3.2 North America Sophocarpidine (CAS：519-02-8) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Sophocarpidine (CAS：519-02-8) Import and Export
      • 5.4 Europe Sophocarpidine (CAS：519-02-8) Market Analysis
        • 5.4.1 Europe Sophocarpidine (CAS：519-02-8) Production
        • 5.4.2 Europe Sophocarpidine (CAS：519-02-8) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Sophocarpidine (CAS：519-02-8) Import and Export
      • 5.5 China Sophocarpidine (CAS：519-02-8) Market Analysis
        • 5.5.1 China Sophocarpidine (CAS：519-02-8) Production
        • 5.5.2 China Sophocarpidine (CAS：519-02-8) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Sophocarpidine (CAS：519-02-8) Import and Export
      • 5.6 Japan Sophocarpidine (CAS：519-02-8) Market Analysis
        • 5.6.1 Japan Sophocarpidine (CAS：519-02-8) Production
        • 5.6.2 Japan Sophocarpidine (CAS：519-02-8) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Sophocarpidine (CAS：519-02-8) Import and Export
      • 5.7 Southeast Asia Sophocarpidine (CAS：519-02-8) Market Analysis
        • 5.7.1 Southeast Asia Sophocarpidine (CAS：519-02-8) Production
        • 5.7.2 Southeast Asia Sophocarpidine (CAS：519-02-8) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Sophocarpidine (CAS：519-02-8) Import and Export
      • 5.8 India Sophocarpidine (CAS：519-02-8) Market Analysis
        • 5.8.1 India Sophocarpidine (CAS：519-02-8) Production
        • 5.8.2 India Sophocarpidine (CAS：519-02-8) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Sophocarpidine (CAS：519-02-8) Import and Export

      6 Sophocarpidine (CAS：519-02-8) Segment Market Analysis (by Type)

      • 6.1 Global Sophocarpidine (CAS：519-02-8) Production by Type
      • 6.2 Global Sophocarpidine (CAS：519-02-8) Revenue by Type
      • 6.3 Sophocarpidine (CAS：519-02-8) Price by Type

      7 Sophocarpidine (CAS：519-02-8) Segment Market Analysis (by Application)

      • 7.1 Global Sophocarpidine (CAS：519-02-8) Consumption by Application
      • 7.2 Global Sophocarpidine (CAS：519-02-8) Consumption Market Share by Application (2014-2019)

      8 Sophocarpidine (CAS：519-02-8) Major Manufacturers Analysis

      • 8.1 Fujie Pharmaceutical
        • 8.1.1 Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.1.2 Fujie Pharmaceutical Product Introduction, Application and Specification
        • 8.1.3 Fujie Pharmaceutical Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 QHL Pharma
        • 8.2.1 QHL Pharma Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.2.2 QHL Pharma Product Introduction, Application and Specification
        • 8.2.3 QHL Pharma Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Select Botanical
        • 8.3.1 Select Botanical Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.3.2 Select Botanical Product Introduction, Application and Specification
        • 8.3.3 Select Botanical Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Indena
        • 8.4.1 Indena Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.4.2 Indena Product Introduction, Application and Specification
        • 8.4.3 Indena Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Qinghai Lake Pharmaceuticals
        • 8.5.1 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.5.2 Qinghai Lake Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 TIANSHAN Pharmaceuticals
        • 8.6.1 TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.6.2 TIANSHAN Pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 TIANSHAN Pharmaceuticals Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Selco Wirkstoffe Vertriebs GmbH
        • 8.7.1 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.7.2 Selco Wirkstoffe Vertriebs GmbH Product Introduction, Application and Specification
        • 8.7.3 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Jiangsu Tiansheng Pharmaceutical
        • 8.8.1 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.8.2 Jiangsu Tiansheng Pharmaceutical Product Introduction, Application and Specification
        • 8.8.3 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Tiansheng Pharmaceutical
        • 8.9.1 Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.9.2 Tiansheng Pharmaceutical Product Introduction, Application and Specification
        • 8.9.3 Tiansheng Pharmaceutical Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Hubei Zhongliao Chemical Co., LTD
        • 8.10.1 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Production Sites and Area Served
        • 8.10.2 Hubei Zhongliao Chemical Co., LTD Product Introduction, Application and Specification
        • 8.10.3 Hubei Zhongliao Chemical Co., LTD Sophocarpidine (CAS：519-02-8) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Sophocarpidine (CAS：519-02-8) Market

      • 9.1 Global Sophocarpidine (CAS：519-02-8) Market Trend Analysis
        • 9.1.1 Global Sophocarpidine (CAS：519-02-8) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Sophocarpidine (CAS：519-02-8) Regional Market Trend
        • 9.2.1 North America Sophocarpidine (CAS：519-02-8) Forecast 2019-2025
        • 9.2.2 Europe Sophocarpidine (CAS：519-02-8) Forecast 2019-2025
        • 9.2.3 China Sophocarpidine (CAS：519-02-8) Forecast 2019-2025
        • 9.2.4 Japan Sophocarpidine (CAS：519-02-8) Forecast 2019-2025
        • 9.2.5 Southeast Asia Sophocarpidine (CAS：519-02-8) Forecast 2019-2025
        • 9.2.6 India Sophocarpidine (CAS：519-02-8) Forecast 2019-2025
      • 9.3 Sophocarpidine (CAS：519-02-8) Market Trend (Product Type)
      • 9.4 Sophocarpidine (CAS：519-02-8) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Sophocarpidine (CAS：519-02-8) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.

        The global Sophocarpidine (CAS：519-02-8) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Sophocarpidine (CAS：519-02-8) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sophocarpidine (CAS：519-02-8) market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Sophocarpidine (CAS：519-02-8) in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Sophocarpidine (CAS：519-02-8) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Fujie Pharmaceutical
        QHL Pharma
        Select Botanical
        Indena
        Qinghai Lake Pharmaceuticals
        TIANSHAN Pharmaceuticals
        Selco Wirkstoffe Vertriebs GmbH
        Jiangsu Tiansheng Pharmaceutical
        Tiansheng Pharmaceutical
        Hubei Zhongliao Chemical Co., LTD

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        High Purity
        Low Purity

        Segment by Application
        Pharmaceuticals
        Pesticides
        Others

        Buy now